Evidence map›Paper›PMID 36014301›Full record

ReviewMolecules (Basel, Switzerland)2022

Pharmacological Profile, Bioactivities, and Safety of Turmeric Oil.

Adriana Monserrath Orellana-Paucar, María Gabriela Machado-Orellana

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cytoprotective Properties of Turmeric Oil (Curcuma longa L.) on Fibroblast Cells.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Natural Products: Therapeutic Properties and Beyond II.Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Adriana Monserrath Orellana-PaucarNutrition and Dietetics School, Faculty of Medical Sciences, University of Cuenca, Cuenca 010204, Ecuador.ORCID 0000-0003-1460-0990
María Gabriela Machado-OrellanaPharmacology and Nutritional Sciences Interdisciplinary Research Group, Faculty of Medical Sciences, University of Cuenca, Cuenca 010204, Ecuador.ORCID 0000-0003-0986-6866

Funding

Research Vice-Chancellorship of the University of Cuenca, Ecuador. It does not apply
6 · The paper itself

Abstract

The pharmacological attributes of turmeric have been extensively described and frequently related to the action of curcuminoids. However, there is also scientific evidence of the contribution of turmeric oil. Since the oil does not contain curcuminoids in its composition, it is crucial to better understand the therapeutic role of other constituents in turmeric. The present review discusses the pharmacokinetics of turmeric oil, pointing to the potential application of its active molecules as therapeutic compounds. In addition, the bioactivities of turmeric oil and its safety in preclinical and clinical studies were revised. This literature-based research intends to provide an updated overview to promote further research on turmeric oil and its constituents.

Indexed as

CurcumaCurcuminDiarylheptanoidsPlant ExtractsCurcuminDiarylheptanoidsPlant ExtractsCurcuma longacurcuma oilpharmacological activitypharmacological profilesafetytoxicityturmericturmeric oil

Identifiers

PMID36014301
PMCPMC9414992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.